Clinical Trial: Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639034) titled 'Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease' on June 03.

Brief Summary: The primary objective of this study is to show that consistent use of Systane PRO over a 30 period will significantly improve the signs and symptoms of Dry Eye Disease and decrease patients' ocular surface disease index score for patients diagnosed with mild-moderate (DED).

Study Start Date: Nov. 01, 2025

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease (DED)

Intervention: DRUG: Systane Pro Topical Ophthalmic

To show that consistent use of Systane PRO will significantly improve the signs and symptoms of Dry Eye Disease in patien...